• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Rocket Lab Announces Third Quarter 2023 Financial Results, Issues Guidance For Fourth Quarter 2023 and Revenue Guidance for First Quarter 2024

    11/8/23 4:10:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials
    Get the next $RKLB alert in real time by email

     

    Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter, ended September 30, 2023.

    Rocket Lab founder and CEO, Peter Beck, said: "Rocket Lab's third quarter began strongly with two successful Electron missions that accelerated our recovery program to make Electron the world's first reusable small orbital rocket. Following the subsequent September 19th anomaly, we've been laser-focused this quarter on the return to service of Electron. The cause of the anomaly is a highly complex set of conditions that are extremely difficult to replicate in testing. However, we believe the findings of the Rocket Lab investigation team overwhelmingly indicate that an electrical arc occurred within the power supply system that provides high voltage to the Rutherford engine's motor controllers, shorting the battery packs which provide power to the launch vehicle's upper stage. With growing confidence in our determination of the anomaly's probable root cause and corrective measures in place, we expect to formally close our investigation in the coming weeks. Electron's return to flight is scheduled during a launch window that opens from November 28, 2023, and extends into December.

    "Over the same period, we've progressed the development of Neutron with numerous achievements including a milestone stage two tank test, the crucial validation of methane and LOX combustion in Archimedes igniter testing, and infrastructure scaling for Neutron launch development and engine testing across Virginia, California, and Mississippi. We've also secured seven HASTE hypersonic missions with prime defense customers in the past six months, demonstrating the success of our market approach for hypersonic test development for the nation. In Space Systems, the production of spacecraft in our largest program, the $143m Globalstar contract with MDA, has continued on schedule ahead of the first spacecraft delivery in Q1 2024. We also continue to ramp on a new spacecraft contract for a confidential customer this current quarter, as Rocket Lab demonstrates its ability to win and execute critical satellite manufacturing contracts."

    Third Quarter 2023 Business Highlights:

    • Launched two successful Electron missions in the third quarter. The missions were back-to-back recovery launches as part of Rocket Lab's program to make Electron the world's first reusable small orbital rocket. The first mission of the quarter deployed seven satellites for customers NASA, SFL, and Spire, before completing a successful ocean splashdown and recovery of Electron's first stage. The second mission of the quarter deployed a satellite for Capella Space and achieved several milestones for Rocket Lab's reusability program, including both another ocean splashdown of the first stage and a successful flight of the previously-flown Rutherford engine for the first time.
    • Confirmed authorization from the Federal Aviation Administration (FAA) to resume Electron launches from Launch Complex 1 following an in-flight anomaly on September 19th during the Company's 41st Electron launch.
    • Announced that Electron will return to the pad at Launch Complex 1 for a dedicated commercial mission for Japan-based Earth imaging customer iQPS during a launch window which opens on November 28, 2023, and extends into December.
    • Continued strong growth in Electron bookings for 2024, with the Company's launch manifest fully allocated for 2024 and into early 2025.

    Business Highlights Since September 30, 2023:

    • Acquired assets and production resources in Warkworth, New Zealand, enabling further vertical integration of critical composites production and design capabilities for both Electron and Neutron rockets. More than 50 staff and accompanying advanced manufacturing assets were retained with the acquisition.
    • Officially opened the Company's Engine Development Center in Long Beach, California that will support the high-rate production of the Electron launch vehicle's Rutherford engine, as well as the development and production of the Neutron launch vehicle's Archimedes engine.
    • Numerous milestone achievements in the Neutron program, including the conclusion of a crucial cryogenic test campaign for the Neutron second stage; completed production of full-scale Archimedes engine structures and components for upcoming development tests; and significant site improvements at both Launch Complex 3 at Wallops Island, Virginia and Archimedes Engine Test Stand in Stennis, Mississippi ahead of Archimedes engine testing and qualification phase.
    • Continued strong growth in HASTE bookings for hypersonic test launches from Rocket Lab Launch Complex 2 in Virginia. Newly-announced HASTE mission for the Defense Innovation Unit (DIU) to deploy a scramjet-powered suborbital payload by Australian company Hypersonix is the seventh launch contract Rocket Lab has secured with prime hypersonic defense customers in the past six months.
    • Secured a new Space Systems contract that includes spacecraft build with key components supplied by Rocket Lab; two significant milestones invoiced as part of the $143m contract with MDA for Globalstar; and Rocket Lab satellite components put into operations in the groundbreaking deep-space NASA Psyche mission deployed on October 13, 2023.

       

    Fourth Quarter 2023 Guidance

    For the Fourth quarter of 2023, Rocket Lab expects:

    • Revenue between $65 million and $69 million.
    • Space Systems revenue between $48.5 million to $52.5 million.
    • Launch Services revenue of approximately $16.5 million.
    • GAAP Gross Margins between 24% to 26%.
    • Non-GAAP Gross Margins between 30% to 32%.
    • GAAP Operating Expenses between $61 million to $63 million.
    • Non-GAAP Operating Expenses between $50 million to $52 million.
    • Expected Interest Expense (Income), net $2 million.
    • Adjusted EBITDA loss of $23 million to $27 million.
    • Basic Shares Outstanding of 487 million.

    For the First quarter 2024, Rocket Lab expects:

    • Revenue between $95 million and $105 million.
    • Space Systems revenue between $65 million to $68 million.
    • Launch Services revenue between $30 million to $37 million.

    See "Use of Non-GAAP Financial Measures" below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q4 2023 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $11 million to $12 million in Q4 2023.

    Conference Call Information

    Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our third quarter, to provide our outlook for the fourth quarter, and other updates.

    The live webcast and a replay of the webcast will be available on Rocket Lab's Investor Relations website: https://investors.rocketlabusa.com/events-and-presentations/events

    About Rocket Lab

    Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle and the Photon satellite platform and is developing the Neutron launch vehicle for large spacecraft and constellation deployment. From its first orbital launch in January 2018 to date, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 171 satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab's Photon spacecraft platform has been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch site in Virginia, USA. To learn more, visit www.rocketlabusa.com.

    + FORWARD LOOKING STATEMENTS

    This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release, including statements regarding our expectations of financial results for the fourth quarter of 2023 and first quarter of 2024, strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. Words such as, but not limited to, "anticipate," "aim," "believe," "contemplate," "continue," "could," "design," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "seek," "should," "suggest," "strategy," "target," "will," "would," and similar expressions or phrases, or the negative of those expressions or phrases, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on Rocket Lab's current expectations and beliefs concerning future developments and their potential effects. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond Rocket Lab's control), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including risks related to delays and disruptions in expansion efforts; delays in the development of our Neutron rocket; our dependence on a limited number of customers; the harsh and unpredictable environment of space in which our products operate which could adversely affect our launch vehicle and spacecraft; increased competition in our industry due in part to rapid technological development; technological change in our industry which we may not be able to keep up with or which may render our services uncompetitive; average selling price trends; general economic uncertainty and turbulence which could impact our customers' ability to pay what we are owed; failure of our launch vehicles, spacecraft and components to operate as intended either due to our error in design in production or through no fault of our own; launch schedule disruptions; supply chain disruptions, product delays or failures; design and engineering flaws; launch failures; natural disasters and epidemics or pandemics; any inability to effectively integrate recently acquired assets; a US government shutdown or delays in government funding; changes in governmental regulations including with respect to trade and export restrictions, or in the status of our regulatory approvals or applications; or other events that force us to cancel or reschedule launches, including customer contractual rescheduling and termination rights; risks that acquisitions may not be completed on the anticipated time frame or at all or do not achieve the anticipated benefits and results; and the other risks detailed from time to time in Rocket Lab's filings with the Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" in Rocket Lab's Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the SEC on March 7, 2023, and elsewhere. There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated. Except as required by law, Rocket Lab is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

    Notes to Editor: All dollar amounts in this press release are expressed in U.S. dollars, unless otherwise stated.

    + USE OF NON-GAAP FINANCIAL MEASURES

    We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America ("GAAP") with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

    + ADJUSTED EDITDA

    EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

    + OTHER NON-GAAP FINANCIAL MEASURES

    Non-GAAP gross profit, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

    (unaudited; in thousands, except share and per share data)

     

     

     

     

     

     

     

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2023

     

     

    2022

     

     

    2023

     

     

    2022

     

    Revenues

     

    $

    67,661

     

     

    $

    63,057

     

     

    $

    184,601

     

     

    $

    159,234

     

    Cost of revenues

     

     

    52,694

     

     

     

    54,590

     

     

     

    148,684

     

     

     

    142,074

     

    Gross profit

     

     

    14,967

     

     

     

    8,467

     

     

     

    35,917

     

     

     

    17,160

     

    Operating expenses:

     

     

     

     

     

     

     

     

     

     

     

     

    Research and development, net

     

     

    26,626

     

     

     

    17,508

     

     

     

    81,566

     

     

     

    50,150

     

    Selling, general and administrative

     

     

    27,200

     

     

     

    22,961

     

     

     

    84,386

     

     

     

    64,991

     

    Total operating expenses

     

     

    53,826

     

     

     

    40,469

     

     

     

    165,952

     

     

     

    115,141

     

    Operating loss

     

     

    (38,859

    )

     

     

    (32,002

    )

     

     

    (130,035

    )

     

     

    (97,981

    )

    Other income (expense):

     

     

     

     

     

     

     

     

     

     

     

     

    Interest income (expense), net

     

     

    (1,413

    )

     

     

    (1,486

    )

     

     

    (2,843

    )

     

     

    (6,907

    )

    Loss on foreign exchange

     

     

    (120

    )

     

     

    (51

    )

     

     

    (76

    )

     

     

    (3,947

    )

    Change in fair value of liability classified warrants

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    13,482

     

    Other income, net

     

     

    1,176

     

     

     

    622

     

     

     

    3,519

     

     

     

    625

     

    Total other (expense) income, net

     

     

    (357

    )

     

     

    (915

    )

     

     

    600

     

     

     

    3,253

     

    Loss before income taxes

     

     

    (39,216

    )

     

     

    (32,917

    )

     

     

    (129,435

    )

     

     

    (94,728

    )

    Provision for income taxes

     

     

    (1,352

    )

     

     

    (1,693

    )

     

     

    (2,639

    )

     

     

    (4,008

    )

    Net loss

     

    $

    (40,568

    )

     

    $

    (34,610

    )

     

    $

    (132,074

    )

     

    $

    (98,736

    )

    Net loss per share attributable to Rocket Lab USA, Inc.:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic and diluted

     

    $

    (0.08

    )

     

    $

    (0.07

    )

     

    $

    (0.28

    )

     

    $

    (0.21

    )

    Weighted-average common shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic and diluted

     

     

    484,034,071

     

     

     

    469,768,797

     

     

     

    480,018,578

     

     

     

    463,709,955

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

    AS OF SEPTEMBER 30, 2023 AND DECEMBER 31, 2022

    (unaudited; in thousands, except share and per share values)

     

     

     

     

     

     

     

     

     

    September 30, 2023

     

     

     

     

     

     

    (unaudited)

     

     

    December 31, 2022

     

    Assets

     

     

     

     

     

     

    Current assets:

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    140,904

     

     

    $

    242,515

     

    Marketable securities, current

     

     

    147,513

     

     

     

    229,276

     

    Accounts receivable, net

     

     

    22,787

     

     

     

    36,572

     

    Contract assets

     

     

    13,042

     

     

     

    9,451

     

    Inventories

     

     

    102,394

     

     

     

    92,279

     

    Prepaids and other current assets

     

     

    68,341

     

     

     

    52,201

     

    Assets held for sale

     

     

    11,259

     

     

     

    —

     

    Total current assets

     

     

    506,240

     

     

     

    662,294

     

    Non-current assets:

     

     

     

     

     

     

    Property, plant and equipment, net

     

     

    135,988

     

     

     

    101,514

     

    Intangible assets, net

     

     

    70,404

     

     

     

    79,692

     

    Goodwill

     

     

    71,020

     

     

     

    71,020

     

    Right-of-use assets - operating leases

     

     

    44,900

     

     

     

    35,239

     

    Right-of-use assets - finance leases

     

     

    15,145

     

     

     

    15,614

     

    Marketable securities, non-current

     

     

    81,951

     

     

     

    9,193

     

    Restricted cash

     

     

    3,588

     

     

     

    3,356

     

    Deferred income tax assets, net

     

     

    3,282

     

     

     

    3,898

     

    Other non-current assets

     

     

    17,975

     

     

     

    7,303

     

    Total assets

     

    $

    950,493

     

     

    $

    989,123

     

    Liabilities and Stockholders' Equity

     

     

     

     

     

     

    Current liabilities:

     

     

     

     

     

     

    Trade payables

     

    $

    24,980

     

     

    $

    12,084

     

    Accrued expenses

     

     

    5,998

     

     

     

    8,723

     

    Employee benefits payable

     

     

    14,979

     

     

     

    8,634

     

    Contract liabilities

     

     

    133,793

     

     

     

    108,344

     

    Current installments of long-term borrowings

     

     

    105,116

     

     

     

    2,906

     

    Other current liabilities

     

     

    18,885

     

     

     

    22,249

     

    Total current liabilities

     

     

    303,751

     

     

     

    162,940

     

    Non-current liabilities:

     

     

     

     

     

     

    Long-term borrowings, excluding current installments

     

     

    —

     

     

     

    100,043

     

    Non-current operating lease liabilities

     

     

    41,695

     

     

     

    34,266

     

    Non-current finance lease liabilities

     

     

    15,299

     

     

     

    15,568

     

    Deferred tax liabilities

     

     

    308

     

     

     

    95

     

    Other non-current liabilities

     

     

    3,638

     

     

     

    3,005

     

    Total liabilities

     

     

    364,691

     

     

     

    315,917

     

    COMMITMENTS AND CONTINGENCIES

     

     

     

     

     

     

    Stockholders' equity:

     

     

     

     

     

     

    Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued and outstanding shares: 485,857,768 and 475,356,517 at September 30, 2023 and December 31, 2022, respectively

     

     

    49

     

     

     

    48

     

    Additional paid-in capital

     

     

    1,161,165

     

     

     

    1,112,977

     

    Accumulated deficit

     

     

    (573,029

    )

     

     

    (440,955

    )

    Accumulated other comprehensive (loss) income

     

     

    (2,383

    )

     

     

    1,136

     

    Total stockholders' equity

     

     

    585,802

     

     

     

    673,206

     

    Total liabilities and stockholders' equity

     

    $

    950,493

     

     

    $

    989,123

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

    (unaudited; in thousands)

     

     

     

     

     

     

    For the Nine Months Ended September 30,

     

     

     

    2023

     

     

    2022

     

    CASH FLOWS FROM OPERATING ACTIVITIES:

     

     

     

     

     

     

    Net loss

     

    $

    (132,074

    )

     

    $

    (98,736

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    21,577

     

     

     

    21,590

     

    Stock-based compensation expense

     

     

    43,398

     

     

     

    43,312

     

    Loss on disposal of assets

     

     

    240

     

     

     

    32

     

    Amortization of debt issuance costs and discount

     

     

    2,166

     

     

     

    2,107

     

    Noncash lease expense

     

     

    4,062

     

     

     

    2,312

     

    Noncash income associated with liability-classified warrants

     

     

    —

     

     

     

    (13,482

    )

    Change in the fair value of contingent consideration

     

     

    1,138

     

     

     

    200

     

    Accretion of marketable securities purchased at a discount

     

     

    (3,399

    )

     

     

    (421

    )

    Deferred income taxes

     

     

    644

     

     

     

    1,167

     

    Changes in operating assets and liabilities:

     

     

     

     

     

     

    Accounts receivable, net

     

     

    13,798

     

     

     

    (30,752

    )

    Contract assets

     

     

    (3,592

    )

     

     

    (6,960

    )

    Inventories

     

     

    (10,933

    )

     

     

    (17,635

    )

    Prepaids and other current assets

     

     

    (15,819

    )

     

     

    (17,173

    )

    Other non-current assets

     

     

    (10,712

    )

     

     

    3,281

     

    Trade payables

     

     

    12,026

     

     

     

    (1,625

    )

    Accrued expenses

     

     

    (2,187

    )

     

     

    (3,530

    )

    Employee benefits payables

     

     

    5,285

     

     

     

    2,519

     

    Contract liabilities

     

     

    25,450

     

     

     

    26,404

     

    Other current liabilities

     

     

    (4,632

    )

     

     

    2,310

     

    Non-current lease liabilities

     

     

    (3,316

    )

     

     

    (2,551

    )

    Other non-current liabilities

     

     

    230

     

     

     

    39

     

    Net cash used in operating activities

     

     

    (56,650

    )

     

     

    (87,592

    )

    CASH FLOWS FROM INVESTING ACTIVITIES:

     

     

     

     

     

     

    Purchases of property, equipment and software

     

     

    (44,293

    )

     

     

    (27,419

    )

    Cash paid for business combinations and asset acquisitions, net of acquired cash and restricted cash

     

     

    (16,934

    )

     

     

    (65,824

    )

    Purchases of marketable securities

     

     

    (207,266

    )

     

     

    (179,853

    )

    Maturities of marketable securities

     

     

    219,340

     

     

     

    240

     

    Net cash used in investing activities

     

     

    (49,153

    )

     

     

    (272,856

    )

    CASH FLOWS FROM FINANCING ACTIVITIES:

     

     

     

     

     

     

    Proceeds from the exercise of stock options and public warrants

     

     

    2,293

     

     

     

    4,278

     

    Proceeds from Employee Stock Purchase Plan

     

     

    3,780

     

     

     

    3,149

     

    Proceeds from sale of employees restricted stock units to cover taxes

     

     

    12,390

     

     

     

    28,587

     

    Minimum tax withholding paid on behalf of employees for restricted stock units

     

     

    (12,352

    )

     

     

    (28,308

    )

    Tax payment for net settled option shares

     

     

    —

     

     

     

    (444

    )

    Payment of contingent consideration

     

     

    (1,000

    )

     

     

    (5,500

    )

    Finance lease principal payments

     

     

    (248

    )

     

     

    (193

    )

    Net cash provided by financing activities

     

     

    4,863

     

     

     

    1,569

     

    Effect of exchange rate changes on cash and cash equivalents

     

     

    (439

    )

     

     

    3,091

     

    Net decrease in cash and cash equivalents and restricted cash

     

     

    (101,379

    )

     

     

    (355,788

    )

    Cash and cash equivalents, and restricted cash, beginning of period

     

     

    245,871

     

     

     

    692,075

     

    Cash and cash equivalents, and restricted cash, end of period

     

    $

    144,492

     

     

    $

    336,287

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

    FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

    (unaudited; in thousands)

     

    The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

     

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2023

     

     

    2022

     

     

    2023

     

     

    2022

     

    NET LOSS

     

    $

    (40,568

    )

     

    $

    (34,610

    )

     

    $

    (132,074

    )

     

    $

    (98,736

    )

    Depreciation

     

     

    4,237

     

     

     

    4,400

     

     

     

    11,463

     

     

     

    11,911

     

    Amortization

     

     

    3,555

     

     

     

    3,453

     

     

     

    10,114

     

     

     

    9,679

     

    Stock-based compensation expense

     

     

    14,098

     

     

     

    14,485

     

     

     

    43,398

     

     

     

    43,312

     

    Transaction costs

     

     

    142

     

     

     

    34

     

     

     

    311

     

     

     

    505

     

    Interest (income) expense, net

     

     

    1,413

     

     

     

    1,486

     

     

     

    2,843

     

     

     

    6,907

     

    Change in fair value of liability classified warrants

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (13,482

    )

    Change in fair value of contingent consideration

     

     

    (462

    )

     

     

    200

     

     

     

    1,138

     

     

     

    200

     

    Performance reserve escrow

     

     

    1,800

     

     

     

    1,894

     

     

     

    5,426

     

     

     

    5,684

     

    Amortization of inventory step-up

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    2,618

     

    Provision for income taxes

     

     

    1,352

     

     

     

    1,693

     

     

     

    2,639

     

     

     

    4,008

     

    Loss on foreign exchange

     

     

    120

     

     

     

    51

     

     

     

    76

     

     

     

    3,947

     

    Accretion of marketable securities purchased at a discount

     

     

    (1,447

    )

     

     

    —

     

     

     

    (3,601

    )

     

     

    —

     

    Loss on disposal of assets

     

     

    213

     

     

     

    7

     

     

     

    240

     

     

     

    32

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    (3,841

    )

     

     

    —

     

    ADJUSTED EBITDA

     

    $

    (15,547

    )

     

    $

    (6,907

    )

     

    $

    (61,868

    )

     

    $

    (23,415

    )

     

     

    Three Months Ended September 30,

     

     

    Nine Months Ended September 30,

     

     

     

    2023

     

     

    2022

     

     

    2023

     

     

    2022

     

    GAAP Gross profit

     

    $

    14,967

     

     

    $

    8,467

     

     

    $

    35,917

     

     

    $

    17,160

     

    Stock-based compensation

     

     

    3,182

     

     

     

    4,964

     

     

     

    10,325

     

     

     

    14,091

     

    Amortization of purchased intangibles

     

     

    1,710

     

     

     

    1,756

     

     

     

    5,129

     

     

     

    3,072

     

    Amortization of inventory step-up

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    2,618

     

    Performance reserve escrow

     

     

    76

     

     

     

    114

     

     

     

    209

     

     

     

    342

     

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    (2,130

    )

     

     

    —

     

    Non-GAAP Gross profit

     

    $

    19,935

     

     

    $

    15,301

     

     

    $

    49,450

     

     

    $

    37,283

     

    Non-GAAP Gross margin

     

     

    29.5

    %

     

     

    24.3

    %

     

     

    26.8

    %

     

     

    23.4

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP Research and development, net

     

    $

    26,626

     

     

    $

    17,508

     

     

    $

    81,566

     

     

    $

    50,150

     

    Stock-based compensation

     

     

    (6,219

    )

     

     

    (5,309

    )

     

     

    (17,893

    )

     

     

    (16,685

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (315

    )

     

     

    (9

    )

     

     

    (333

    )

     

     

    (3,333

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    631

     

     

     

    —

     

    Non-GAAP Research and development, net

     

    $

    20,092

     

     

    $

    12,190

     

     

    $

    63,971

     

     

    $

    30,132

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP Selling, general and administrative

     

    $

    27,200

     

     

    $

    22,961

     

     

    $

    84,386

     

     

    $

    64,991

     

    Stock-based compensation

     

     

    (4,697

    )

     

     

    (4,212

    )

     

     

    (15,180

    )

     

     

    (12,536

    )

    Amortization of purchased intangibles

     

     

    (1,378

    )

     

     

    (1,529

    )

     

     

    (4,207

    )

     

     

    (2,907

    )

    Transaction costs

     

     

    (142

    )

     

     

    (34

    )

     

     

    (311

    )

     

     

    (505

    )

    Performance reserve escrow

     

     

    (1,724

    )

     

     

    (1,781

    )

     

     

    (5,217

    )

     

     

    (5,343

    )

    Change in fair value of contingent consideration

     

     

    462

     

     

     

    (200

    )

     

     

    (1,138

    )

     

     

    (200

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    1,080

     

     

     

    —

     

    Non-GAAP Selling, general and administrative

     

    $

    19,721

     

     

    $

    15,205

     

     

    $

    59,413

     

     

    $

    43,500

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP Operating expenses

     

    $

    53,826

     

     

    $

    40,469

     

     

    $

    165,952

     

     

    $

    115,141

     

    Stock-based compensation

     

     

    (10,916

    )

     

     

    (9,521

    )

     

     

    (33,073

    )

     

     

    (29,221

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (1,693

    )

     

     

    (1,538

    )

     

     

    (4,540

    )

     

     

    (6,240

    )

    Transaction costs

     

     

    (142

    )

     

     

    (34

    )

     

     

    (311

    )

     

     

    (505

    )

    Performance reserve escrow

     

     

    (1,724

    )

     

     

    (1,781

    )

     

     

    (5,217

    )

     

     

    (5,343

    )

    Change in fair value of contingent consideration

     

     

    462

     

     

     

    (200

    )

     

     

    (1,138

    )

     

     

    (200

    )

    Employee retention credit

     

     

    —

     

     

     

    —

     

     

     

    1,711

     

     

     

    —

     

    Non-GAAP Operating expenses

     

    $

    39,813

     

     

    $

    27,395

     

     

    $

    123,384

     

     

    $

    73,632

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP Operating loss

     

    $

    (38,859

    )

     

    $

    (32,002

    )

     

    $

    (130,035

    )

     

    $

    (97,981

    )

    Total non-GAAP adjustments

     

     

    18,981

     

     

     

    19,908

     

     

     

    56,101

     

     

     

    61,632

     

    Non-GAAP Operating loss

     

    $

    (19,878

    )

     

    $

    (12,094

    )

     

    $

    (73,934

    )

     

    $

    (36,349

    )

     

     

     

     

     

     

     

     

     

     

     

     

     

    GAAP Total other income (expense), net

     

    $

    (357

    )

     

    $

    (915

    )

     

    $

    600

     

     

    $

    3,253

     

    Change in fair value of liability classified warrants

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    (13,482

    )

    Loss on foreign exchange

     

     

    120

     

     

     

    51

     

     

     

    76

     

     

     

    3,947

     

    Non-GAAP Total other income (expense), net

     

    $

    (237

    )

     

    $

    (864

    )

     

    $

    676

     

     

    $

    (6,282

    )

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231108450544/en/

    Get the next $RKLB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RKLB

    DatePrice TargetRatingAnalyst
    1/16/2026$105.00Equal-Weight → Overweight
    Morgan Stanley
    1/15/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    11/12/2025$55.00 → $63.00Buy
    Needham
    10/16/2025$83.00Outperform
    Robert W. Baird
    7/28/2025$51.00Hold
    Craig Hallum
    6/30/2025$27.00Neutral
    Goldman
    4/25/2025$28.00Buy
    Needham
    9/12/2024Mkt Perform
    JMP Securities
    More analyst ratings

    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Olson Jon A sold $1,388,221 worth of shares (15,205 units at $91.30), decreasing direct ownership by 4% to 345,630 units (SEC Form 4)

    4 - Rocket Lab Corp (0001819994) (Issuer)

    1/22/26 6:12:13 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Director Saintil Merline sold $9,436,680 worth of shares (108,500 units at $86.97), decreasing direct ownership by 28% to 280,029 units (SEC Form 4)

    4 - Rocket Lab Corp (0001819994) (Issuer)

    1/15/26 5:15:11 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Chief Financial Officer Spice Adam C. exercised 731,330 shares at a strike of $1.09 and sold $103,112,280 worth of shares (1,365,665 units at $75.50), decreasing direct ownership by 32% to 1,359,568 units (SEC Form 4)

    4 - Rocket Lab Corp (0001819994) (Issuer)

    1/6/26 6:24:12 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $RKLB
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Rocket Lab Corporation

    SCHEDULE 13D/A - Rocket Lab Corp (0001819994) (Subject)

    2/17/26 4:15:01 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Rocket Lab Corp (0001819994) (Filer)

    1/21/26 9:03:42 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    SEC Form 144 filed by Rocket Lab Corporation

    144 - Rocket Lab Corp (0001819994) (Subject)

    1/14/26 4:28:03 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $RKLB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The New Space Race Isn't About Rockets. It's About Who Builds Them

    VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary — The global commercial space launch market, valued at $8.2 billion in 2024, is projected to nearly quadruple to $31.9 billion by 2034 as small satellite demand accelerates[1]. Congress approved $839 billion in defense spending for fiscal 2026, including $4 billion for missile warning and tracking satellites and $13.4 billion to integrate space and missile defense systems[2]. Companies positioned at the intersection of commercial launch and national security include Starfighters Space (NYSE-A: FJET), Rocket Lab (NASDAQ:RKLB), L3Harris Technologies (NYSE:LHX), Intuitive Machines (NASDAQ:LUNR) and N

    2/24/26 11:13:16 AM ET
    $LHX
    $LUNR
    $NOC
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical

    Pentagon Pours $68M Into Hypersonic Tech: Here Are Five Firms Building the Hardware

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 19, 2026 /CNW/ -- USANewsGroup.com News Commentary – The Pentagon's Joint Hypersonics Transition Office has awarded $68 million across six vendors to accelerate next-generation technologies capable of traveling faster than Mach 5[1]. The U.S. Army has begun fielding Dark Eagle, the nation's first operational ground-launched hypersonic weapon, with delivery expected to complete in early 2026[2]. Companies positioned at the intersection of commercial aerospace and defense testing include Starfighters Space (NYSE-A: FJET), Rocket Lab (NASDAQ:RKLB), Intuitive Machines (NASDAQ:LUNR), Kratos Defense & Security Solutions (NASDAQ:KTOS), and J

    2/19/26 9:45:00 AM ET
    $FJET
    $JOBY
    $KTOS
    Air Freight/Delivery Services
    Consumer Discretionary
    Aerospace
    Industrials

    Rocket Lab Prepares To Launch Latest Hypersonic Test Mission for Defense Innovation Unit

    LONG BEACH, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced its next launch is a dedicated mission on its HASTE rocket for the Department of War's Defense Innovation Unit (DIU). The mission, named Cassowary Vex, is scheduled to launch no earlier than late February from Rocket Lab Launch Complex 2 within the Virginia Spaceport Authority's Mid-Atlantic Regional Spaceport on Wallops Island, Virginia. The HASTE launch, dubbed ‘That's Not A Knife," is the latest mission of the DIU and will deploy DART AE, a scramjet-powered aircraft developed by Australian aero

    2/12/26 4:30:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rocket Lab USA upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Rocket Lab USA from Equal-Weight to Overweight and set a new price target of $105.00

    1/16/26 8:21:34 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab USA downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Rocket Lab USA from Overweight to Sector Weight

    1/15/26 8:33:55 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Needham reiterated coverage on Rocket Lab USA with a new price target

    Needham reiterated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $63.00 from $55.00 previously

    11/12/25 8:03:22 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $RKLB
    Financials

    Live finance-specific insights

    View All

    Rocket Lab Announces Date of Fourth Quarter and Full Year 2025 Financial Results

    LONG BEACH, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that it will release its financial results for the fourth quarter and full year 2025 following the close of the U.S. markets on Thursday February 26, 2026. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at www.investors.rocketlabcorp.com. Rocket Lab Investor Relations Contact Patrick [email protected] Rocke

    1/26/26 4:45:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab Announces Third Quarter 2025 Financial Results, Posts Record Quarterly Revenue of $155m, Representing 48% Year-on-Year Growth at Record Gross Margin

    LONG BEACH, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab", "the Company", "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter ended September 30, 2025. Rocket Lab founder and CEO, Sir Peter Beck, said: "This past quarter we've once again delivered record revenue of $155m at record GAAP gross margin of 37%, and a new annual launch record is just days away. With progress across our major space systems programs, record backlog of contracts for our launch services business, and well-timed, strategic M&A in growth areas that are well-aligned with next-generation d

    11/10/25 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab Announces Date of Third Quarter 2025 Financial Results

    LONG BEACH, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that it will release its financial results for the third quarter 2025 following the close of the U.S. markets on Monday November 10, 2025. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at www.investors.rocketlabcorp.com. Rocket Lab Investor Relations Contact Patrick [email protected] Rocket Lab Media Contact Mur

    10/22/25 4:30:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $RKLB
    Leadership Updates

    Live Leadership Updates

    View All

    Niron Magnetics Expands Board of Directors with Seasoned Technology and Finance Experts to Lead the Next Chapter of Growth

    Jon Olson, current Board Member at AMD, Rocket Lab, and Kulicke & Soffa, and Eric Stang, CEO and Chairman of Ooma and current Board Member of Rambus, join Niron Magnetics' Board of Directors Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, announced the appointment of Jon Olson and Eric Stang to its Board of Directors. Their deep experience in technology, finance, and scaling high-growth public and private companies will help guide Niron Magnetics' journey as it expands manufacturing, commercial operations, and global partnerships in preparation for future growth. "Niron Magnetics is entering a pivotal moment. We're sca

    11/12/25 10:00:00 AM ET
    $AMD
    $KLIC
    $OOMA
    Semiconductors
    Technology
    EDP Services
    Military/Government/Technical

    Rocket Lab Schedules Fifth Electron Mission for Constellation Operator iQPS

    Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the launch window for its next mission for multi-launch customer, Institute for Q-shu Pioneers of Space, Inc. (iQPS), a Japan-based Earth imaging company – marking Electron's 69th mission to date and 11th launch this year. The mission, named ‘The Harvest Goddess Thrives', is scheduled to launch from Rocket Lab Launch Complex 1 in New Zealand during a launch window that opens on August 5, 2025 UTC. The mission will deploy QPS-SAR-12, nicknamed KUSHINADA-I for the Japanese goddess of harvest and prosperity, to a 575km circular Earth orbit to join the re

    7/31/25 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab Awarded New HASTE Launch Contract for the DOD by Kratos

    Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it has been selected by Kratos to launch a full-scale hypersonic test flight for the Department of Defense (DOD) under the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0 program. The mission will launch on Rocket Lab's HASTE rocket from Rocket Lab Launch Complex 2 on Wallops Island, Virginia no earlier than Q1, 2026. The launch agreement is the first full-scale flight test to be awarded by Kratos under the MACH-TB 2.0 contract, a $1.45 billion program designed to rapidly expand the number and frequency of opportunities to test hypers

    4/23/25 4:30:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $RKLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/3/24 9:39:57 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

    SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    11/12/24 4:45:55 PM ET
    $RKLB
    Military/Government/Technical
    Industrials